The cost-effectiveness of vaccination against lyme disease

Vaccination against Lyme disease appears to be safe and effective; however, the cost per quality-adjusted life-year (QALY) gained with vaccination is unknown. The authors developed a decision-analytical model to evaluate cost-effectiveness of vaccination compared with no vaccination in individuals living in endemic areas of Lyme disease.